Studie der Universität Texas, 9.11.2026 (engl. Original)
What degrees of satisfaction, regret, and harm are reported by transgender and gender-diverse participants who initiated testosterone or estrogen therapy (ie, hormone therapy [HT]) as youth, and are these experiences associated with demographic or clinical characteristics?
In this cohort study of 372 participants who received care at a single multidisciplinary clinic, satisfaction with HT was high and regret and harm were rare. Decisional regret was slightly higher among youths not currently receiving HT and those identifying on the nonbinary spectrum, but it remained low in absolute terms.
Results provide support for existing standards of care rather than broad restrictions on youths’ access to HT.
Die vollständige Studie finden Sie hier.